The functional interaction between integrin a6b4 and growth factor receptors has been implicated in key signaling pathways important for cancer cell function. However, few attempts have been made to selectively target this interaction for therapeutic intervention. Previous studies showed that curcumin, a yellow pigment isolated from turmeric, inhibits integrin a6b4 signaling important for breast carcinoma cell motility and invasion, but the mechanism is not currently known. To address this issue, we tested the hypothesis that curcumin inhibits the functional interaction between a6b4 and the epidermal growth factor receptor (EGFR). In this study, we found that curcumin disrupts functional and physical interactions between a6b4 and EGFR, and blocks a6b4/EGFR-dependent functions of carcinoma cells expressing the signaling competent form of a6b4. We further showed that curcumin inhibits EGF-dependent mobilization of a6b4 from hemidesmosomes to the leading edges of migrating cells such as lammelipodia and filopodia, and thereby prevents a6b4 distribution to lipid rafts where functional interactions between a6b4 and EGFR occur. These data suggest a novel paradigm in which curcumin inhibits a6b4 signaling and functions by altering intracellular localization of a6b4, thus preventing its association with signaling receptors such as EGFR. Mol Cancer Ther; 10(5); 883-91. Ó2011 AACR.